AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Appendix 4D and Half-year Financial Report, page-7

  1. 2,755 Posts.
    lightbulb Created with Sketch. 471
    The auditors are flagging cash flow problems in the near term as indicated below:
    "To meet the Group’s funding requirements as and when they fall due the Consolidated Entity will need to take appropriate steps, including a combination of:
    ● Raising capital by one of or a combination of the following: placement of shares, rights issue, share purchase plan, etc;
    ● Potential debt financing of the R&D tax incentive so the Group can receive the money in advance; and
    ● Defer certain R&D expenditure to the future to reduce the cash outflows."
    Kens
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $53 17.73K

Buyers (Bids)

No. Vol. Price($)
47 100545147 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 34049380 23
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
0.3¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.3¢ 0.3¢ 0.3¢ 2512384
Last updated 15.59pm 07/06/2024 ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.